These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 18001452)

  • 1. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
    Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB.
    Kainz C; Speiser P; Wanner C; Obermair A; Tempfer C; Sliutz G; Reinthaller A; Breitenecker G
    Anticancer Res; 1995; 15(4):1549-51. PubMed ID: 7544572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal status: a possible predictive factor for recurrence in women with cancer of the uterine cervix without pelvic lymph node metastasis.
    Fregnani JH; Latorre MR; Novik PR; Lopes A; Soares FA
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):204-9. PubMed ID: 19450920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
    Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
    Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
    Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
    Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
    Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence].
    Hellebrekers BW; Zwinderman AH; Kenter GG; Peters AA; Fleuren GJ; Trimbos JB
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2304-9. PubMed ID: 11143298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
    Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
    Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.